Ascend Therapeutics US LLC Therapeutics

Founded in 2002, Ascend Therapeutics Inc. is a biopharmaceutical company focused on the development and use of transdermal drug delivery technology for treatment of chronic conditions. Based in Herndon, VA., its products include first transdermal gel for estrogen therapy, epidermis drugs and hydroalcoholic gels, to name a few. Ascend Therapeutics Inc. conducts research in several therapeutic areas, such as breast pain, breast cancer as well as late-onset hypogonadism. Some of the company's drugs are under clinical development and formulation or preclinical stages.

Cingulate Therapeutics is a clinical stage biopharmaceutical company based in Morristown, NJ, specializing in the development of innovative product candidates for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and anxiety associated disorders. With a focus on precision and control, Cingulate is utilizing a novel erosion-based controlled release technology to develop ADHD medications capable of achieving precise once-daily dosing. With two product candidates, CTX-1301 and CTX-1302, targeting the multi-billion dollar U.S. ADHD market, and a third candidate, CTX-2103, aimed at the U.S. anxiety market, Cingulate is at the forefront of advancing treatments for these neurobiological disorders. Through their Precision Timed Release Platform, which incorporates proprietary erosion barrier layers and specialized compression technology, Cingulate is revolutionizing drug release and delivery, offering new hope for patients and healthcare providers.Generated from the website

Hawthorn Pharmaceuticals Inc, located in Morristown, NJ, is home to Currax Pharmaceuticals LLC, a patient-focused company dedicated to addressing smoking and obesity, the leading causes of preventable deaths in the U.S. Currax has been recognized as one of Nashville Business Journal’s Best Places to Work for three consecutive years, reflecting high employee satisfaction. Specializing in both branded and generic pharmaceuticals, Currax offers a variety of products, including Contrave®, Onzetra® Xsail®, Silenor®, Treximet®, and the authorized generic of Treximet®. The company's commitment to providing access to life-changing medications is reflected in its range of offerings. With a strong emphasis on innovation and corporate responsibility, Currax Pharmaceuticals LLC continues to make strides in the pharmaceutical industry, as seen through its involvement in clinical trials, compliance programs, and educational grants. By prioritizing patient well-being and employee satisfaction, Currax stands out as a reputable and forward-thinking pharmaceutical company. Generated from the website content